Payer

The board of directors for Orange, Calif.-based CalOptima Health  has approved a $526.2 million investment to increase pay rates for hospitals, providers, community clinics, behavioral health providers, ancillary services providers and health networks.  

A federal lawsuit from UnitedHealth Group was dismissed in May against two former executives, which alleged they stole and used confidential company information to create their own competing product for diabetes management.

UnitedHealth Group's board of directors authorized a $2.10 per-share cash dividend to be paid on June 25. 

The financial headwinds facing major Medicare Advantage carriers are also affecting companies across the Blue Cross Blue Shield system.

An Elevance Health executive said the company is comfortable with its Medicare Advantage business as other insurers project losses. 

Around 1 in 3 employers covered GLP-1 drugs for weight loss in 2023, a survey from the International Foundation of Employee Benefit Plans found. 

Legislation aiming to reform the Medicare Advantage prior authorization process has the backing of 389 national and state organizations, ranging from the American Hospital Association to Humana. 

The majority of ACA marketplace plans cover GLP-1 drugs approved for diabetes, though fewer than 1% of plan formularies include drugs solely approved to treat obesity, a new analysis from KFF shows. 

CMS has recalculated Medicare Advantage plans' star ratings after insurers challenging the agency's methodology were handed court victories. 

Here are five lawsuits, settlements and legal developments involving payers that Becker's has reported since May 22: